Related references
Note: Only part of the references are listed.Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer
Tetsuya Mitsudomi et al.
CANCER SCIENCE (2007)
Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification process
Kanako Hoshi et al.
CLINICAL CANCER RESEARCH (2007)
Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers
Tomoaki Tanaka et al.
CANCER SCIENCE (2007)
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer
Junichi Soh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer
Yasushi Yatabe et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer
Hideharu Kimura et al.
CLINICAL CANCER RESEARCH (2006)
Surfactant proteins SP-A and SP-D: Structure, function and receptors
U Kishore et al.
MOLECULAR IMMUNOLOGY (2006)
Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay
H Asano et al.
CLINICAL CANCER RESEARCH (2006)
Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells
T Kitazaki et al.
LUNG CANCER (2005)
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma
Y Yatabe et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence
T Mitsudomi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
VA Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
MG Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer
M Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/Extracellular Signal-regulated Kinase cascade and Sp1
M Perrais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Antisense inhibition of epidermal growth factor receptor decreases expression of human surfactant protein A
JM Klein et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Surfactant protein C expression in urethane-induced murine pulmonary tumors
RJ Mason et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent
H Takahashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
